Managing Emerging Infectious Disease: Clinical Laboratory Response to the COVID-19 Pandemic;Course ID: MPBH 495-011 / HSM 355-008
School:Parkinson School of Health Sciences and Public Health
Program: Medical Lab Sciences, Public Health, Health Sciences
Credit Hours: 1
Course DescriptionThe sudden emergence of the SARS-CoV-2 virus sparked world-wide demand for testing to confirm a diagnosis of COVID-19 disease. Medical Laboratory Scientists are specially trained healthcare professionals, certified to provide data that assist in diagnosis, treatment, monitoring and prevention of disease. Collaborations between Microbiologists, Hematologists, Chemists, and Molecular Specialists provide the objective criteria for diagnosis while Immunologists and Immunohematologists guide potential treatment and vaccination movements. In this course, students will explore the efforts of Medical Laboratory Scientists and the clinical laboratories that make up the backbone behind the development, validation, and performance of testing needed to identify those infected by the virus and displaying biomarkers for the more serious disease. Students will participate in discussions on utility of Laboratory Developed Tests, the process for obtaining emergency use authorization by laboratories and commercial manufacturers in the face of novel disease, as well as criteria for convalescent plasma therapies.
- Identify the role of Medical Laboratory Scientists in combating COVID-19 disease.
- Evaluate the impact of Laboratory Developed Tests and manufactured assays in detecting novel emerging infectious agents.
- Differentiate testing to confirm current versus past SARS-CoV-2 infections and immunity. Explore indications for use of plasma from patients with immunity to SARS-CoV-2 as potential treatment for COVID-19.
This is a special six-week session that runs June 1-July 10, 2020
|C||Fri||10:00 AM - 12:00 PM||Dr. Kamran Mirza|